Federation des caisses Desjardins du Quebec’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $694K | Sell |
4,431
-368
| -8% | -$55.2K | ﹤0.01% | 1242 |
|
|
2026
Q1 | $733K | Buy |
4,799
+244
| +5% | +$37.4K | ﹤0.01% | 1127 |
|
|
2025
Q4 | $628K | Sell |
4,555
-1,549
| -25% | -$203K | ﹤0.01% | 1197 |
|
|
2025
Q3 | $783K | Sell |
6,104
-131
| -2% | -$16K | ﹤0.01% | 1043 |
|
|
2025
Q2 | $754K | Sell |
6,235
-1,688
| -21% | -$190K | ﹤0.01% | 937 |
|
|
2025
Q1 | $883K | Buy |
7,923
+42
| +0.5% | +$4.47K | ﹤0.01% | 864 |
|
|
2024
Q4 | $767K | Sell |
7,881
-622
| -7% | -$66.3K | ﹤0.01% | 859 |
|
|
2024
Q3 | $978K | Sell |
8,503
-24
| -0.3% | -$2.72K | ﹤0.01% | 787 |
|
|
2024
Q2 | $908K | Sell |
8,527
-1,046
| -11% | -$105K | ﹤0.01% | 800 |
|
|
2024
Q1 | $926K | Sell |
9,573
-56,150
| -85% | -$5.76M | 0.01% | 742 |
|
|
2023
Q4 | $6.64M | Sell |
65,723
-1,365
| -2% | -$132K | 0.06% | 224 |
|
|
2023
Q3 | $6.83M | Buy |
67,088
+58,603
| +691% | +$5.95M | 0.07% | 210 |
|
|
2023
Q2 | $856K | Sell |
8,485
-72
| -0.8% | -$7.2K | 0.01% | 652 |
|
|
2023
Q1 | $787K | Sell |
8,557
-1,904
| -18% | -$166K | 0.01% | 653 |
|
|
2022
Q4 | $949K | Sell |
10,461
-130
| -1% | -$10.9K | 0.01% | 593 |
|
|
2022
Q3 | $805K | Buy |
10,591
+66
| +0.6% | +$5.47K | 0.01% | 637 |
|
|
2022
Q2 | $890K | Sell |
10,525
-166
| -2% | -$14.6K | 0.01% | 634 |
|
|
2022
Q1 | $938K | Buy |
10,691
+174
| +2% | +$15.1K | 0.01% | 668 |
|
|
2021
Q4 | $920K | Sell |
10,517
-178
| -2% | -$14.8K | 0.01% | 685 |
|
|
2021
Q3 | $875K | Buy |
10,695
+83
| +0.8% | +$7.47K | 0.01% | 725 |
|
|
2021
Q2 | $968K | Sell |
10,612
-3,681
| -26% | -$328K | 0.01% | 712 |
|
|
2021
Q1 | $1.22M | Sell |
14,293
-451
| -3% | -$40.5K | 0.01% | 622 |
|
|
2020
Q4 | $1.39M | Sell |
14,744
-917
| -6% | -$80.1K | 0.02% | 564 |
|
|
2020
Q3 | $1.36M | Buy |
15,661
+576
| +4% | +$49.9K | 0.02% | 489 |
|
|
2020
Q2 | $1.32M | Buy |
15,085
+373
| +3% | +$32.2K | 0.02% | 483 |
|
|
2020
Q1 | $1.21M | Buy |
14,712
+297
| +2% | +$26.5K | 0.02% | 472 |
|
|
2019
Q4 | $1.36M | Buy |
14,415
+87
| +0.6% | +$7.81K | 0.02% | 564 |
|
|
2019
Q3 | $1.25M | Buy |
14,328
+431
| +3% | +$38.7K | 0.02% | 582 |
|
|
2019
Q2 | $1.27M | Sell |
13,897
-2,624
| -16% | -$222K | 0.02% | 576 |
|
|
2019
Q1 | $1.42M | Sell |
16,521
-14,083
| -46% | -$1.13M | 0.02% | 507 |
|
|
2018
Q4 | $2.35M | Buy |
30,604
+2,156
| +8% | +$168K | 0.04% | 351 |
|
|
2018
Q3 | $2.2M | Buy |
28,448
+1,231
| +5% | +$91K | 0.03% | 431 |
|
|
2018
Q2 | $1.84M | Sell |
27,217
-209
| -0.8% | -$14.4K | 0.03% | 495 |
|
|
2018
Q1 | $1.99M | Sell |
27,426
-768
| -3% | -$58.5K | 0.03% | 453 |
|
|
2017
Q4 | $2.12M | Buy |
28,194
+352
| +1% | +$26.6K | 0.03% | 447 |
|
|
2017
Q3 | $2.14M | Sell |
27,842
-7,430
| -21% | -$561K | 0.03% | 422 |
|
|
2017
Q2 | $2.64M | Buy |
+35,272
| New | +$2.5M | 0.04% | 332 |
|
Other funds holding NVS
Federation des caisses Desjardins du Quebec's NVS Position: Q2 2026 in Review
Federation des caisses Desjardins du Quebec reduced its Novartis (NVS) stake by 7.7% in Q2 2026, selling an estimated $55.2K and leaving 4,431 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.
Federation des caisses Desjardins du Quebec first reported a position in NVS in Q2 2017 and has held it in 37 quarters since. The position peaked at $6.83M in Q3 2023. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Federation des caisses Desjardins du Quebec held 4,431 shares of Novartis worth $694K as of Q2 2026.
- Federation des caisses Desjardins du Quebec sold 368 Novartis shares in Q2 2026, an estimated $55.2K.
- Novartis made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1242 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Novartis in Q2 2017 and has held it in 37 quarters since.
- Federation des caisses Desjardins du Quebec's Novartis position peaked at $6.83M in Q3 2023.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.